Azalea Candelaria serves as the Head of Development at the Aplastic Anemia & MDS International Foundation, where she leverages over 25 years of experience in nonprofit executive management to drive impactful fundraising initiatives and enhance organizational sustainability. In her current role, Azalea is pivotal in...
Azalea Candelaria serves as the Head of Development at the Aplastic Anemia & MDS International Foundation, where she leverages over 25 years of experience in nonprofit executive management to drive impactful fundraising initiatives and enhance organizational sustainability. In her current role, Azalea is pivotal in crafting and executing comprehensive fundraising strategies that encompass special event fundraising, major donor engagement, and annual giving campaigns. Her expertise in volunteer management and board development has been instrumental in cultivating a robust network of supporters and advocates for patients and families affected by aplastic anemia, myelodysplastic syndrome (MDS), and related bone marrow failure diseases.
Under Azalea's leadership, the Foundation has launched several key projects aimed at increasing awareness and support for these rare conditions. She has spearheaded innovative fundraising events that not only raise critical funds but also foster community engagement and education about the challenges faced by patients. Her strategic planning skills have enabled the organization to build a strong infrastructure that supports long-term growth and sustainability, ensuring that the Foundation can continue to provide vital resources and hope to those in need.
Azalea's results-driven approach is complemented by her commitment to leadership development, both within the organization and the broader community. By empowering volunteers and board members, she cultivates a culture of collaboration and shared purpose, which is essential for advancing the Foundation's mission. Through her dedication and expertise, Azalea Candelaria is making a significant impact in the nonprofit sector, enhancing the lives of countless individuals affected by bone marrow failure diseases.
